Edelweiss
Edelweiss House, Off C.S.T. Road, Kalina, Mumbai, Maharashtra, 400 098, India
Overview
Edelweiss is a financial conglomerate that offers a diverse range of products and services. It provides a solid platform to a diverse client base spread across domestic and global geographies. Its priority is to understand customers' needs and provide appropriate financial solutions. Its key lines of business are present in every financial life stage of a customer, assisting them in creating wealth, growing wealth, and protecting everything.
- Total investments
- 17
- Lead investments
- 8
- Investments · 12mo
- 4
- Active investors
- 9
Sector focus
- Finance
- Financial Services
- Wealth Management
Investment portfolio
- Arboreal Bioinnovations
Led · Series A · Jul 2026
Arboreal Bioinnovations develops specialty ingredients and ingredient solutions for nutraceutical, food, beverage, and CPG brands, focusing on categories such as next generation proteins, sugar reduction solutions, cocoa ingredients, natural zero-calorie sweeteners, and functional fibres. Its ingredient technology platform combines ingredient engineering, process R&D, formulation science, and precision manufacturing to commercialize proprietary ingredients. The company follows a contextual innovation approach to tailor solutions to the nutritional, functional, sensory, and commercial requirements of Indian consumers and brands. Arboreal has commercialized proprietary ingredients across multiple categories while additional ingredient platforms remain under development. The company says its products are used by food, beverage, and CPG brands in the Indian market and currently serves more than 1,100 B2B customers across India. With the Series A proceeds, Arboreal plans to expand manufacturing capacity, boost R&D capabilities, and accelerate commercialization of its next-generation functional ingredients.
- Turtlemint
Participated · Equity · Jun 2026
Turtlemint is positioned as an insurtech firm preparing to go public via an IPO scheduled to open on June 19, 2026. As part of the IPO process the company secured ₹397.20 crore from anchor investors at a price of ₹152 per share. The planned IPO aims to raise total proceeds of ₹883 crore, which includes an offer-for-sale component of ₹221 crore. The anchor allocation comprised 26.13 million equity shares, with a substantial portion (11.11 million shares) allotted to domestic mutual fund schemes. The company has engaged ICICI Securities, Jefferies India, JM Financial and Motilal Oswal as book-running lead managers for the offering. No additional operational metrics or financial performance figures were disclosed in the article.
- WeWork India
Participated · Equity · Oct 2025
Founded in May 2016 and headquartered in Bengaluru, WeWork India provides a range of flexible workspace solutions under the global WeWork brand. Its portfolio spans 59 operational centres with 94,440 desks across 6.48 million square feet of leasable area as of September 30 2024. Management states the business is now self-sustaining, having invested heavily in infrastructure over the past eight years and recently using internal funds to pay down debt. Current cash generation is sufficient to fund ongoing operations and further expansion, so the company is not seeking primary capital in its IPO. Instead, the listing is intended to provide liquidity and position the company for future growth opportunities using existing resources. WeWork India benefits from affiliation with WeWork Global, which operates in 35 countries and roughly 600 locations worldwide, augmenting brand recognition and enterprise customer acquisition.
- Lenskart
Participated · Equity · Oct 2025
Lenskart operates as a multi-category eyewear retailer, offering prescription eyeglasses, sunglasses and contact lenses under its own brand. The company caters to customers looking for affordable and stylish vision-care products. In preparation for its public listing, Lenskart has set an IPO price band of ₹382–₹402 per share. Ahead of the IPO, it has already secured significant capital through an anchor allocation, reflecting institutional confidence in the business. While detailed revenue or user metrics were not disclosed, the sizable anchor book suggests robust market interest and expectations for continued growth. The upcoming IPO will provide additional capital for expansion and operational initiatives once the public issue is completed.
- Renee Cosmetics
Participated · Series C · Aug 2025
RENEE Cosmetics develops and sells cosmetic and beauty products, aiming to capture Indian and international consumers through both online and offline channels. The company reported an annual revenue run rate of ₹500 crore and plans to double this to ₹1,000 crore within two years. Management attributes its nearly three-fold growth over the last 18 months to strong consumer adoption, innovation-led product launches, and expansion across retail outlets. RENEE’s products are currently available in 15,000 physical stores, and the brand is testing international demand with a beta online presence in the US, UAE, and Australia. Fresh capital will be directed toward broadening the product portfolio, scaling omnichannel distribution in Tier 1 and Tier 2 Indian cities, and investing in technology and brand-building. The company also plans to strengthen its offline distribution engine to accelerate the next phase of growth.